BioEcho Wins In Vitro Diagnostic CE Mark Approval for SARS-CoV-2 RNA Extraction Kit
BioEcho has received the In Vitro Diagnostic CE Mark Approval for its new SARS-CoV-2 RNA extraction kit which enables viral
Read moreBioEcho has received the In Vitro Diagnostic CE Mark Approval for its new SARS-CoV-2 RNA extraction kit which enables viral
Read moreFrench pharma giant Sanofi is set to acquire Tidal Therapeutics for $470m, adding the biotech’s novel mRNA-based research platform with
Read moreCureVac intends to expand its COVID-19 vaccine candidate clinical trial in order to be able to determine efficacy for select
Read morePfizer and BioNTech have published early in vitro study data showing that the BNT162b2 COVID-19 vaccine generates antibodies that neutralise
Read moreModerna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
Read moreModerna announced its vaccine candidate against COVID-19 named mRNA-1273, has met Phase 3 study statistical criteria with a vaccine efficacy
Read moreCureVac, a German biopharmaceutical company developing innovative medicines based on messenger ribonucleic acid (mRNA), announced that its mRNA-based COVID-19 vaccine
Read morePfizer and BioNTech announced this week that they have reached an agreement with the European Commission to supply 200 million
Read morePfizer and BioNTech have announced their mRNA-based vaccine candidate for COVID-19, tested in a Phase 3 study involving 43,538 participants,
Read moreAmerican biotech Moderna has signed an agreement with the Ministry of Public Health to supply Qatar with its mRNA COVID-19
Read more